DURAPHARMA ApS: Financial statements 2014
CVR: 29916055
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
DURAPHARMA ApS (CVR 29916055) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -716,677 and a net result of DKK -983,284 compared with DKK -813,776 the year before. Equity in the 2014 report amounted to DKK -4,453,605.
- Gross Profit
- DKK -716,677
- Profit/Loss
- DKK -983,284
- Equity
- DKK -4,453,605
- Total Assets
- DKK 133,197
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -717 t. | -983 t. | -4.5 mio. | - |
| 2013 | - | -569 t. | -814 t. | -3.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
DURAPHARMA ApS has published its annual report for 2013. Gross profit came to DKK -568,580, and the net result was DKK -813,776.
As of March 12, 2014, Revisorgruppen v/Gotfredsen I/S has been appointed auditor of DURAPHARMA ApS.
As of March 12, 2014, SØREN JENSEN has stepped down as auditor of DURAPHARMA ApS.
About DURAPHARMA ApS
DURAPHARMA ApS was a Danish company of the type Anpartsselskab based in Stenstrup, founded in 2006. The company has been dissolved on 3 November 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2018). In 2018, the company reported a gross profit of DKK -386,631 and a net result of DKK -1,127,797 compared with DKK -1,498,230 the year before. Equity in the 2018 report amounted to DKK -9,567,805.